TrialAnnals of medicine2024

A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases.

Dayong Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.